SUBSCRIBE
SUBSCRIBE

Nexus Pharmaceuticals, Inc.

IN THE PRESS
Policy
Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin
May 5, 2023
 · 
2 min read
FDA
Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe
March 1, 2023
 · 
3 min read
BioMidwest
Nexus Pharmaceuticals Announces Launch of Sterile Vial Product Line
February 22, 2023
 · 
2 min read
FDA
Nexus Pharmaceuticals Inc. Receives FDA Approval for Tirofiban Hydrochloride Injection
February 9, 2023
 · 
1 min read
Business
Nexus Pharmaceuticals Announces Usman Ahmed as President and Chief Executive Officer
October 3, 2022
 · 
2 min read
BioMidwest
Nexus Pharmaceuticals Announces Launch of Erythromycin Lactobionate for Injection, USP
April 21, 2022
 · 
1 min read
FDA
Nexus Pharmaceuticals Inc. Receives FDA Approval of Erythromycin Lactobionate for Injection, USP
February 17, 2022
 · 
1 min read
BioMidwest
Nexus Pharmaceuticals Receives Patent for EMERPHED® Ready-To-Use Ephedrine Sulfate Injection
August 17, 2021
 · 
3 min read
BioMidwest
Nexus Pharmaceuticals Announces Launch of Potassium Chloride in Water for Injection
July 26, 2021
 · 
2 min read
Business
Nexus Pharmaceuticals Celebrates Grand Opening of New, State-of-the-Art Manufacturing Facility
July 19, 2021
 · 
3 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS